BackAryx Therapeutics Overview

Aryx Therapeutics EBIT

EBIT (Earnings Before Interest and Taxes) analysis for ARYX.

Quarterly EBIT

-$2.15M
72.85% YoY

As of Sep 30, 2010

Annual EBIT (TTM)

-$16.73M
56.79% YoY

Trailing 12 months ending Sep 30, 2010

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)